Hospira, Inc. (HSP) Tops Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts HSP Hot Sheet
Price: $89.95 --0%
Financial Fact:
Diluted (in shares): 176.1M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Diluted (in shares): 176.1M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Hospira, Inc. (NYSE: HSP) reported Q2 EPS of $0.51, $0.02 better than the analyst estimate of $0.49. Revenue for the quarter came in at $1.03 billion versus the consensus estimate of $987.02 million.
Hospira, Inc. reaffirmed FY2012 guidance.
For earnings history and earnings-related data on Hospira, Inc. (HSP) click here.
Hospira, Inc. reaffirmed FY2012 guidance.
For earnings history and earnings-related data on Hospira, Inc. (HSP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
- LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
